Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thai Nguyen-Cleary
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
99 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Innsbruck Medical University
Innsbruck, Austria
- Univ.-Kklinik Fuer Innere Medizin Iii
Salzburg, Austria
- Medical University of Vienna
Vienna, Austria
- Otto-Wagner-Spital
Vienna, Austria
- Ucl Saint Luc
Brussels, Belgium
- University Hospital Ghent
Ghent, Belgium
- Chu Sart Tilman
Liège, Belgium
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Clinique Medicale Du Quartier Latin
Montreal, Quebec, Canada
- Chu de Besancon, Hopital Saint-Jacques
Besançon, France
- Hôpital de la Croix-Rousse
Lyon, France
- Chu Hôpital Gui de Chauliac
Montpellier, France
- Archet 1 Chu Nice Department of Infectology
Nice, France
- Hopital Saint Antoine
Paris, France
- Hôpital Bichat-Claude Bernard
Paris, France
- Maladies Infectieuses Dpt
Paris, France
- Saint-Louis Hospital
Paris, France
- Hôpital Tenon
Paris, France
- Hôpital Haut Lévêque
Pessac, France
- Epimed Gmbh
Berlin, Germany
- University of Bonn
Bonn, Germany
- Infektlonsambulanz Unlkllnik Koln
Cologne, Germany
- Universitätsklinikum Essen, Dermatologie, Hiv Ambulanz
Essen, Germany
- Johann Wolfgang Goethe-University Hospital / Infectious Diseases Hs 68
Frankfurt, Germany
- Ich Study Center
Hamburg, Germany
- Universitätsklinikum Hamburg-Eppendorf, Ambulanzzentrum Des Uke Gmbh, Bereich Infektiologie
Hamburg, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- Infektionsambulanz, Med Poliklink, Klinikum Der Universitat Munchnen
Munich, Germany
- Ospedali Riuniti
Bergamo, Italy
- Clinic of Infectious Diseases, University of Milan-San Paolo Hospital
Milan, Italy
- Fondazione Centro San Raffaele
Milan, Italy
- Ospedale Luigi Sacco
Milan, Italy
- National Institute for Infectious Diseases "l. Spallanzani"
Rome, Italy
- University of Torino, Dept of Infectious Disease
Torino, Italy
- Hhp Hospital de Cascais
Alcabideche, Portugal
- Hospital Santo Antonio Dos Capuchos, Centro Hospitalar de Lisboa
Lisbon, Portugal
- Hospital de Santa Maria-Chln, Epe
Lisbon, Portugal
- Clinical Research Puert Rico
San Juan, Puerto Rico
- University of Puerto Rico School of Medicine
San Juan, Puerto Rico
- Hospital General Universitario Alicante
Alicante, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 30 Nov 2013
- Completion
- 31 Dec 2014
- Last update posted
- 8 Jun 2016
- Registered enrollment
- 438
- Registry id
- NCT01475838
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.